Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Spark Therap (ONCE)

Spark Therap (ONCE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Spark Therap 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 USA

P: 888-772-7560

Description:

Spark Therapeutics, Inc. offers gene therapy. The Company's product candidate consist of SPK-RPE65, SPK-CHM, SPK-FIX which are in different clinical phases, for the treatment of additional blinding conditions, hematologic disorders and neurodegenerative diseases. Spark Therapeutics, Inc. is based in Philadelphia, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 4,375,056
Shares Outstanding, K 38,523
Annual Sales, $ 64,730 K
Annual Net Income, $ -78,820 K
Last Quarter Sales, $ 22,450 K
Last Quarter Net Income, $ -66,600 K
60-Month Beta 2.05
% of Insider Shareholders 6.00%
% of Institutional Shareholders 88.37%
Float, K 36,212
% Float 94.00%

Growth:

1-Year Return 172.74%
3-Year Return 119.76%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.67 on 02/19/19
Next Earnings Date 11/26/19
Earnings Per Share ttm -6.56
EPS Growth vs. Prev Qtr -3.61%
EPS Growth vs. Prev Year -36.51%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ONCE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -37.52
Price/Earnings to Growth N/A
Return-on-Equity % -59.10%
Return-on-Assets % -33.13%
Profit Margin % -121.77
Net Margin % N/A
Debt/Equity 0.30
Price/Sales 65.92
Price/Cash Flow N/A
Price/Book 12.63
Book Value/Share 8.99
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar